Connect with us

Hi, what are you looking for?

Tuesday, Jan 25, 2022
Mugglehead Magazine
Cannabis & psychedelics industry news based in Vancouver, B.C.
  • Loading stock data...

Business

Numinus to start trading on TSX

The firm will celebrate by ringing the opening bell at the stock exchange on Thursday

Numinus to graduate listing and start trading on TSX
Photo via Numinus

Psychedelic therapeutic firm Numinus Wellness Inc. (TSXV: NUMI) (OTCQX: NUMIF) will start listing on the Toronto Stock Exchange this week.

In a statement Tuesday, the Vancouver-based company says it will be graduating its listing from the TSX-Venture Exchange to the TSX, starting Thursday at market open.

The same day, Numinus says it will celebrate by ringing the opening bell of the TSX, where founder and CEO Payton Nyquvest will be joined by other senior management.

Common shares will be traded on the TSX under the symbol “NUMI” and listed warrants will trade under the symbols “NUMI.WT”, “NUMI.WT.B” and “NUMI.WT.C.”

There isn’t any action required by shareholders and there’s no change to shares, warrants or the firm’s share structure.

Read more: Numinus ends fiscal year with revenue up 72% to $1.5M, losses of $19M

Read more: Numinus set to open Canada’s first psychedelics neurology centre

Numinus has four wellness clinics that deliver psychedelic-assisted therapy across Canada — one in Vancouver and the rest in Montreal.

According to the firm’s latest quarterly earnings report, 650 people received 2,671 therapy appointments via Numinus Health clinics that included individual and group sessions during the three-month period. The number of client appointments had grown 42 per cent in the first quarter of 2022.

Recently, Numinus has started expanding its psychedelics research facility, including building an additional lab dedicated to testing, study as well as research and development for other compounds like ketamine and LSD.

Earlier this year, the firm filed a provisional patent application in the U.S. for a proprietary rapid production process for psilocybe and other types of psychoactive fungi.

And Numinus has received approval from Health Canada for a study sponsored by the Multidisciplinary Association of Psychedelic Studies evaluating MDMA-assisted therapy for PTSD.

 

Follow Mugglehead on Twitter

Like Mugglehead on Facebook

Follow Kathryn Tindale on Twitter

kathryn@mugglehead.com

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Health and Safety

Science doesn't know yet, but one psychedelic researcher is chasing clues to see if it can

Canada

As more medium-to-small producers came into play this year, great weed started hitting legal shelves at fairer prices

Culture

Punishments for possession include caning and the death penalty. Despite a global trend of reform, The Fine City remains staunch in its anti-drug stance

Analysis

While legal weed businesses decry enforcement of their accounts, the platform says it's keeping its all-ages community safe